SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-036950
Filing Date
2022-10-12
Accepted
2022-10-12 16:15:36
Documents
14
Period of Report
2022-10-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10042877_8k.htm   iXBRL 8-K 28760
2 EXHIBIT 99.1 brhc10042877_ex99-1.htm EX-99.1 20840
6 image00001.jpg GRAPHIC 3159
  Complete submission text file 0001140361-22-036950.txt   196921

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20221012.xsd EX-101.SCH 3872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20221012_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20221012_pre.xml EX-101.PRE 16049
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10042877_8k_htm.xml XML 4239
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 221307014
SIC: 2834 Pharmaceutical Preparations